s6y

3 Cellectar Biosciences, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001144204-17-047185

Documents

  1. FORM 3 3
  2. EXHIBIT 24 EX-24

On sec.gov